Nanjing BioPAS Pharmaceutical Equipment Technology Co., Ltd.

作者:刘翔宇 发布时间:2020-08-18
Nanjing BioPAS Pharmaceutical Equipment Technology Co., Ltd.

百帕斯(安曼)

Nanjing BioPAS Pharmaceutical Equipment Technology Co., Ltd.

Dedicated in pharmaceutical automation turnkey project and bioreactor design & manufacturing.


Nanjing BioPAS is originally Nanjing A & M Technology Co. , Ltd. and be transferred the whole business of automation business in this new firm, and will keep the original pharmaceutical automation engineering capacity and team, with a full range of qualifications and rich project experience. We specialize in the integrated automation solution of API production in accordance with GMP regulatory requirements and meeting the instinct safety diagnostic requirements.


The bioreactor (fermentor) developed by BioPAS, fully automatic embedded, combined with the characteristics of mammalian cell culture process, equipped with internationally renowned instrument valves and control system, developed an innovative technology of stainless steel bioreactor (fermentor) and micro reactors (fermentor). it is suitable for Cell cultured or bacterial fermented drugs such as monoclonal antibodies, vaccines or recombinant proteins from pilot to scale up production.


BP-SCADA is a production management software and data integration platform developed in depth based on biopharmaceutical processes and characteristics, covering the upstream and downstream processes of biopharmaceutical raw material production. Suitable for data collection and intelligent production management of all production stages of monoclonal antibodies, vaccines, recombinant proteins and other biological products, applicable to stainless steel production, hybrid production and disposable production.

 


0
-1